| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2011 | CN101422427B Magnesium isoglycyrrhizinate cream and preparation method and use thereof |
| 06/22/2011 | CN101416987B Honey acid mixture, preparation and application thereof |
| 06/22/2011 | CN101411784B Preparation technique of compound oral liquid for tonifying blood containing red skin of peanut |
| 06/22/2011 | CN101370493B Hydronol preparation |
| 06/22/2011 | CN101365432B Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 06/22/2011 | CN101361749B Steroid saponin compound and use thereof in preparing anti-tumor medicine |
| 06/22/2011 | CN101347432B Long-acting enrofloxacin injection for livestock and poultry and method of preparing the same |
| 06/22/2011 | CN101322786B External-use medicament for treating bone fracture and traumatic injury |
| 06/22/2011 | CN101293905B Benzoxazole ketone glycoside compounds and preparation method thereof |
| 06/22/2011 | CN101277698B Quinoline derivatives as antibacterial agents |
| 06/22/2011 | CN101259161B Production technology of cream for treating toothache and odontitis |
| 06/22/2011 | CN101239980B Immunity receptor regulator couplet precursor, couplet and application thereof |
| 06/22/2011 | CN101239189B Tenofovir, adefovir and intelligent polymer conjugates and preparation and use thereof |
| 06/22/2011 | CN101213164B Aryl dihydro-naphthalene compounds, their preparation and their use as Akt inhibitor for the prevention and treatment of cancer |
| 06/22/2011 | CN101209271B Medicinal composition for preventing helicobacter pylori |
| 06/22/2011 | CN101194980B Powder medicament for treating otitis media suppurative |
| 06/22/2011 | CN101182563B Method for preparing lactulose by co-immobilized lactose enzyme and glucose isomerase |
| 06/22/2011 | CN101175758B Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 06/22/2011 | CN101175747B Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 06/22/2011 | CN101166532B Micronized tanaproget, compositions, and methods of preparing the same |
| 06/22/2011 | CN101151032B Pharmaceutical composition and method using antifungal agent in combination |
| 06/22/2011 | CN101144081B Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 06/22/2011 | CN101143011B Method for improving iron bioavailability in food |
| 06/22/2011 | CN101130061B Segmented intestine targeted drug feeding preparation of myocardium protein polypeptide and method of producing the same |
| 06/22/2011 | CN101120949B Traditional Chinese medicine for treating haemorrhoids |
| 06/22/2011 | CN101115749B Aminopyrimidine compounds and methods of use |
| 06/22/2011 | CN101115742B Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/22/2011 | CN101111498B Cefcapene pivoxil methanesulfonate |
| 06/22/2011 | CN101108847B (+) doxazosin mesylate, method of manufacturing the same and use thereof |
| 06/22/2011 | CN101084885B Two sustained-release preparations containing cinnamic acid for preventing coxsackie virus and preparation technology thereof |
| 06/22/2011 | CN101062045B Use of triterpene saponin compounds in preparing tumor medicine |
| 06/22/2011 | CN101060848B Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
| 06/22/2011 | CN101044247B Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/22/2011 | CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 06/22/2011 | CN101020047B Health food containing calcium reinforcing agent |
| 06/22/2011 | CN101011354B Asarone submicron emulsion and its preparation method |
| 06/22/2011 | CN101006055B 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964753 Formoterol tartrate process and polymorph |
| 06/21/2011 | US7964738 Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives |
| 06/21/2011 | US7964734 Raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 06/21/2011 | US7964730 Amino-substituted ethylamino β2 adrenergic receptor agonists |
| 06/21/2011 | US7964727 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome |
| 06/21/2011 | US7964726 1-(1,3-benzodioxol-5-yl)-N-(3,5-dimethylphenyl)-1,9-dihydrospiro[ beta -carboline-4,1'-cyclopropane]-2(3H)-carboxamide; mitochondrial benzodiazepine receptor modulator; digestive system disease caused by stress: irritable bowel syndrome, ulcerative colitis, or Crohn's disease |
| 06/21/2011 | US7964724 Chiral cis-imidazolines |
| 06/21/2011 | US7964717 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene |
| 06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964650 Carbonyl-functionalized thiophene compounds and related device structures |
| 06/21/2011 | US7964649 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| 06/21/2011 | US7964648 Methods for concomitant administration of colchicine and a second active agent |
| 06/21/2011 | US7964647 Colchicine compositions and methods |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964645 Di-aromatic substituted amides as inhibitors for GlyT-1 |
| 06/21/2011 | US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means |
| 06/21/2011 | US7964643 Biphenyl-4-sulfonic acid-(4-hydroxybutyl)-amide and derivatives; inhibits osteoclast survival, formation, and/or activity and/or inhibits bone resorption; osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, antiinflammatory, -carcinogenic agents; immunostimulants |
| 06/21/2011 | US7964642 Antiinflammatory agents, analgesics; 2-halo-4-hydroxy-5-methoxyphenyl-functional urea or thiourea compounds such as 1-(p-trifluoromethylbenzyl)-3-(2-iodo-4-hydroxy-5-methoxybenzyl)thiourea |
| 06/21/2011 | US7964641 administering lipid glycerides for treating neurodegenerative disease such as multiple sclerosis; increasing transforming growth factors and tumor necrosis factors |
| 06/21/2011 | US7964640 Oligomers of straight-chain and unbranched fatty acids and drugs containing these |
| 06/21/2011 | US7964639 Modified retinoid compounds and their uses |
| 06/21/2011 | US7964638 Skin cosmetic and wrinkle-reducing agent |
| 06/21/2011 | US7964637 Process for producing optically active theaspirane |
| 06/21/2011 | US7964636 Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases |
| 06/21/2011 | US7964635 Amidoacetonitrile derivatives |
| 06/21/2011 | US7964634 Therapeutic compounds |
| 06/21/2011 | US7964633 such as N,N'-[hexane-1,6-diylbis(iminocarbonyl)]bis(3-chlorobenzenesulfonamide), used as Fructose-1,6-bisphosphatase inhibitors; metabolic disorders such as diabetes |
| 06/21/2011 | US7964632 Methods of treatment using a prodrug of an excitatory amino acid |
| 06/21/2011 | US7964631 Fused tricyclic compounds as inhibitors of tumor necrosis factor-α |
| 06/21/2011 | US7964630 Topical application agents against mimic and age-related wrinkles |
| 06/21/2011 | US7964629 2-[5-(3-Methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil) and derivatives; anticarcinogenic agents; leukemia; antiinflammatory agents; multiple sclerosis, antiarthritic agents; rheumatic diseases;osteoporosis, stroke, asthma; glaucoma; screening; catalyzed CaaX protein methylation |
| 06/21/2011 | US7964628 Fibrinogen receptor antagonists and their use |
| 06/21/2011 | US7964626 Process for producing N,N′-carbonyldiimidazole |
| 06/21/2011 | US7964625 Antibiotics comprising bis(1-aryl-5-tetrazoly1)methane derivatives |
| 06/21/2011 | US7964624 Inhibitors of serine proteases |
| 06/21/2011 | US7964623 Tricyclic benzopyrane compound |
| 06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 06/21/2011 | US7964621 Thioamide compounds, method of making and method of using thereof |
| 06/21/2011 | US7964620 Imidazole derivatives |
| 06/21/2011 | US7964619 Teraryl components as antiparasitic agents |
| 06/21/2011 | US7964618 2-[(3R)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]-3-piperidyl]acetic acid, for example; compounds possess human 11- beta-hydroxysteroid dehydrogenase type1 enzyme (11 beta HSD1) inhibitory activity and accordingly have value in treatment of disease states including metabolic syndrome |
| 06/21/2011 | US7964617 Methods for treating parkinsons disease and parkinsonism |
| 06/21/2011 | US7964616 Compounds 679 |
| 06/21/2011 | US7964615 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor |
| 06/21/2011 | US7964614 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 06/21/2011 | US7964613 Sulfonamide compound |
| 06/21/2011 | US7964612 Therapeutic pyrazolyl thienopyridines |
| 06/21/2011 | US7964610 Buprenorphine derivatives and uses thereof |
| 06/21/2011 | US7964609 Use of mGluR5 antagonists for the treatment of gerd |
| 06/21/2011 | US7964608 Tricyclic compounds as modulators of TNF-α synthesis |
| 06/21/2011 | US7964607 Pyrazolo[3,4-d]pyrimidine compounds |
| 06/21/2011 | US7964606 Therapeutic agents useful for treating pain |
| 06/21/2011 | US7964605 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof |
| 06/21/2011 | US7964604 Bifeprunox mesylate maintenance dose compositions and methods for using the same |
| 06/21/2011 | US7964603 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments |
| 06/21/2011 | US7964602 Biaryl compounds useful as agonists of the Gpr38 receptor |
| 06/21/2011 | US7964601 Agonist or antgonist and binders and inversion of agonist |
| 06/21/2011 | US7964600 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 06/21/2011 | US7964599 Therapeutic compounds |
| 06/21/2011 | US7964598 ApoE4 domain interaction inhibitors and methods of use thereof |